The transmission ultrasound technology is designed to generate high-fidelity 360° images of the breast, QT Ultrasound said. The company is currently conducting a clinical trial program to determine if transmission ultrasound technology can help reduce callback and false-positive biopsy rates, as well as replace screening mammography.